INVESTORS & MEDIA
News Release
January 13, 2017 at 12:00 AM EST
Sanofi and Regeneron File Notice of Appeal and Motion to Stay (Suspend) Injunction with Federal Circuit Court of Appeals in Patent Case Regarding Praluent® (alirocumab) Injection
Sanofi and Regeneron File Notice of Appeal and Motion to Stay (Suspend) Injunction with Federal Circuit Court of Appeals in Patent Case Regarding Praluent® (alirocumab) Injection